Rathan M. Subramaniam

Research interests

Publications

• Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03128

• Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non–Small Cell Lung Cancer

  Radiographics · 2018 · 10.1148/rg.2018180060

• Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT

  American Journal of Roentgenology · 2018 · 10.2214/ajr.18.19881

• Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy

  Annals of Internal Medicine · 2016 · 10.7326/m15-1456

• FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies

  The Oncologist · 2016 · https://doi.org/10.1634/theoncologist.2015-0353

• Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing

  Annals of Oncology · 2015 · 10.1093/annonc/mdv109

• Brain PET in the Diagnosis of Alzheimer’s Disease

  Clinical Nuclear Medicine · 2014 · https://doi.org/10.1097/rlu.0000000000000547

• Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes

  Journal of Nuclear Medicine · 2014 · 10.2967/jnumed.113.136796

• Brain FDG PET and the Diagnosis of Dementia

  American Journal of Roentgenology · 2014 · https://doi.org/10.2214/ajr.13.12363

• 18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging

  Journal of Nuclear Medicine · 2012 · 10.2967/jnumed.111.099531

• Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction

  The Journal of Experimental Medicine · 1998 · https://doi.org/10.1084/jem.188.2.409

Current projects

No projects listed.